ENDRA Life Sciences (NDRA) Change in Accured Expenses (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Change in Accured Expenses of $79908.0 for Q1 2026, up 216.48% year-over-year from $25249.2 in Q1 2025, and up 260.02% quarter-over-quarter from -$49937.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Change in Accured Expenses (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Change in Accured Expenses for 11 consecutive years, with $79908.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 216.48% year-over-year to $79908.0; the TTM figure through Mar 2026 stood at $261799.0 (up 143.26% YoY), while the FY2025 annual figure was $113287.0, up 156.97% from the prior year.
- Change in Accured Expenses improved to $79908.0 in Q1 2026 per NDRA's latest filing, from -$49937.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $337711.0 in Q1 2024 and bottomed at -$1.3 million in Q4 2023.
- Historically, Change in Accured Expenses has averaged -$42138.5 across 5 years, with a median of $79908.0 in 2026.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 400.8% — and 2023, when it tumbled 3524.36%.
- ENDRA Life Sciences' Change in Accured Expenses stood at -$35085.0 in 2022, then sank by 3524.36% to -$1.3 million in 2023, then surged by 90.19% to -$124769.0 in 2024, then soared by 59.98% to -$49937.0 in 2025, then soared by 260.02% to $79908.0 in 2026.
- Business Quant data shows NDRA's Change in Accured Expenses at $79908.0 in Q1 2026, -$49937.0 in Q4 2025, and $223095.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -249.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -39.33 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 92.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 23.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -24.00 Mn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | -53,553.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -53,553.00 |
| Jun 30, 2026 | -53,553.00 |
| Mar 31, 2026 | 79,908.00 |
| Mar 31, 2026 | 79,908.00 |
| Dec 31, 2025 | -49,937.00 |
| Dec 31, 2025 | -49,937.00 |
| Sep 30, 2025 | 223,095.00 |
| Sep 30, 2025 | 223,095.00 |
| Jun 30, 2025 | 8,733.00 |
| Jun 30, 2025 | 8,733.00 |
| Mar 31, 2025 | -68,604.00 |
| Mar 31, 2025 | -68,604.00 |
| Dec 31, 2024 | -124,769.00 |
| Dec 31, 2024 | -124,769.00 |
| Sep 30, 2024 | -540,778.00 |
| Sep 30, 2024 | -540,778.00 |
| Jun 30, 2024 | 128,969.00 |
| Jun 30, 2024 | 128,969.00 |
| Mar 31, 2024 | 337,711.00 |
| Mar 31, 2024 | 337,711.00 |